6-O-Sulfo sialylparagloboside and sialyl Lewis X neo-glycolipids containing lactamized neuraminic acid: Synthesis and antigenic reactivity against G159 monoclonal antibody
Synthesis and antigenic reactivity of 6-O-sulfo sialylparagloboside (SPG) and sialyl Lewis X (sLe X ) neo-glycolipids containing lactamized neuraminic acid are described. The suitably protected GlcNAc-β (1 → 3)-Gal-β (1 → 4)-GlcOSE derivative was glycosylated with NeuTFAc-α (2 → 3)-Gal imidate to give NeuTFAc-α (2 → 3)-Galβ (1 → 4)-GlcNAc-β (1 → 3)-Gal-β (1 → 4)-GlcOSE pentasaccharide. The partial N,O-deacylation in the NeuTFAc-α (2→3)-Gal part afforded N-deacetylated SPG derivative which was converted to the desired oligosaccharide containing lactamized neuraminic acid. Similar treatment of the sLeX hexasaccharide derivative, NeuTFAc-α (2 → 3)-Gal-β (1 → 4) [Fuc-α (1 →3)]-GlcNAc-β (1 → 3)-Gal-β (1 → 4)-GlcOSE, gave the key hexasaccharide intermediate containing lactamized neuraminic acid. These suitably protected SPG and sLex oligosaccharides were converted stepwise into the desired neo-glycolipids (GSC-551 and GSC-552) by the coupling with 2-(tetradecyl)hexadecanol, 6-O-sulfation at C-6 of the GlcNAc residure, and complete deprotection.
Both lactamized-sialyl 6-O-sulfo SPG (GSC-551) and sLex (GSC-552) neo-glycolipids were clearly recognized with G159 monoclonal antibody showing that both the lactamized neuraminic acid and the 6-O-sulfate at C-6 of GlcNAc would be involved in the G159-defined determinant. However, the Fuc residue and the lipophilic (ceramide) part may not be critical for this recognition. Published in 2005
Unable to display preview. Download preview PDF.
- 4.Kannagi R, Mitsuoka C, Ohmori K, Kanamori A, Kiso M, Khoo K.-H, Inoue Y, Cyclic sialic acid: A new regulatory mechanism of selectin ligand activity. In Sialobiology and Other Novel Forms of Glycosylation, edited by Inoue Y, Lee YC, Troy FA, (Gakushin Publisher, Osaka, Japan, 1999) pp. 37–43.Google Scholar
- 6.Mitsuoka C, Kawakami-Kimura N, Kasugai-Sawada M, Hiraiwa N, Toda K, Ishida H, Kiso M, Hasegawa A, Kannagi R, Sulfated sialyl Lewis X, the putative L-selectin ligand, detected on endothelial cells of high endothelial venules by a distinct set of anti-sialyl Lewis X antibodies, Biochem Biophys Res Commun 230, 546–51 (1997).CrossRefPubMedGoogle Scholar
- 7.Galustian C, Lawson AM, Komba S, Ishida H, Kiso M, Feizi T, Sialyl-Lewisx sequence 6-O-sulfated at N-acetylglucosamine rather than at galactose is the preferred ligand for L-selectin and de-N-acetylation of the sialic acid enhances the binding strength, Biochem Biophys Res Commun 240, 748–51 (1997).CrossRefGoogle Scholar
- 8.Mitsuoka C, Sawada-Kasugai M, Ando-Furui K, Izawa M, Nakanishi H, Nakamura S, Ishida H, Kiso M, Kannagi R, Identification of a major carbohydrate capping group of the L-selectin ligand on high endothelial venules in human lymph nodes as 6-sulfo sialyl Lewis X, J Biol Chem 273, 11225–33 (1998).CrossRefPubMedGoogle Scholar
- 12.Yamaguchi M, Ishida H, Kanamori A, Kannagi R, Kiso M, Studies on the endogenous L-selectin ligands: Systematic and highly efficient total synthetic routes to lactamized-sialyl 6-O-sulfo Lewis x and other novel gangliosides containing lactamized neuraminic acid, Carbohydr Res 338, 2793–812 (2003).CrossRefPubMedGoogle Scholar
- 14.Fukunaga K, Shinoda K, Ishida H, Kiso M, Systematic synthesis of sulfated sialyl-α (2 → 3)-neolactotetraose derivatives and their acceptor specificity for a α (1 → 3)-fucosyltransferase (Fuc-TVII) involved in the biosynthesis of L-selectin ligand, Carbohydr Res 328, 85–94 (2000).CrossRefPubMedGoogle Scholar